Introducción a la Genómica


Julia María Lesher Gordillo
Carlos Alfonso Tovilla Zárate

Palabras clave:

Biología molecular, Genoma humano, Molecular Biology, Human Genome


Esta obra constituye una introducción para el lector interesado en las ciencias genómicas, un viaje que empieza desde los conceptos básicos de DNA y RNA hasta los dilemas éticos que aún hoy son foco de discusión para la sociedad.
Una revisión tanto histórica como conceptual que explora uno de los tantos misterios del ser humano, un auxiliar en la comprensión de una disciplina en construcción.


Introduction to Genomics

This work constitutes an introduction for the reader interested in the genomic sciences, a journey that begins from the basic concepts of DNA and RNA to the ethical dilemmas that are still the focus of discussion for society today. A review both historical and conceptual that explores one of the many mysteries of the human being, an aid in understanding a discipline under construction.


MCPHERSON JD, Marra M, Hillier L, Waterston RH, Chinwalla A, Wallis J, et al. A physical map of the human genome. Nature. 2001 Feb 15; 409 (6822):934-941.

VENTER JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The sequence of the human genome. Science. 2001 Feb 16; 291 (5507): 1304-1351.

Finishing the euchromatic sequence of the human genome. International Human Genome Sequencing Consortium. Nature. 2004 Oct 21; 431 (7011): 931-945.

RANA TM. Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol. 2007 Jan; 8 (1): 23-36.

WOODSIDE MT, García-García C, Block SM. Folding and unfolding single RNA molecules under tension. Curr Opin Chem Biol. 2008 Dec; 12 (6): 640-648.

WILUSZ JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009 Jul 1; 23 (13): 1494-1504.

CHASTAIN M, Tinoco I Jr. Structural elements in RNA. Prog Nucleic Acids Res Mol Biol. 1991; 41: 131-177. 8. Shen LX, Cai Z, Tinoco I Jr. RNA structure at high resolution. FASEB. 1995 Aug ; 9 (11): 1023-1033.

ZEMORA G, Waldsich C. RNA folding in living cells. RNA Biol. 2010 Nov 1; 7 (6): 8-15.

KORNBERG RD. The molecular basis of eukaryotic transcription. Proc Nat Acad Sci. USA. 2007 Aug 7; 104 (32): 12955-12961.

BIRNEY E, Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 2007 Jun 14; 447 (7146): 799–816.

HAHN S. Structure and mechanism of the RNA polymerase II transcription machinery. Nat Struct Mol Biol 2004 May; 11 (5): 394-403.

JONES KA, Yamamoto KR, Tjian R. Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro. Cell. 1985 Sep; 42 (2): 559-572.

SANTORO C, Mermod N, Andrews PC, Tjian R. A family of human CCAAT-box- binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs. Nature. 1988 Jul 21; 334 (6179); 218-224.

GIDONI D, Dynan WS, Tjian R. Multiple specific contacts between a mammalian transcription factor and its cognate promoters. Nature. 1984 Nov 29-Dec 5; 312 (5993): 409-413.

PROKUNINA L, Alarcón-Riquelme ME. Regulatory SNPs in complex diseases: their identification and functional validation. Expert Rev Mol Med. 2004 Apr 27; 6 (10): 1-15.

WILL CL, Lührmann R. Spliceosome structure and function. The RNA world. Third edition 2006. páginas 369-400.

RAMIREZ-BELLO J, Pérez-Méndez O, Ramírez-Fuentes S, Carrillo-Sánchez S, Vargas-Alarcón G, Fragoso JM. Genética y genómica de la hipertensión arterial: una actualización en estudios genómicos. Arch Cardiol Mex. In press.

BURKHARDT R, Kenny EE, Lowe JK, Birkeland A, Josowitz R, Noel M, et al. Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon 13. Arterioscler Thromb Vasc Biol. 2008 Nov; 28 (11): 2078-2084.

KOMAR AA. SNPs, silent but not invisible. Science. 2007 Jan 26; 315 (5811); 466-467.

SHASTRY BS. SNPs: impact on gene function and phenotype. Methods Mol Biol.2009; 578: 3-22.

HUNT R, Sauna ZE, Ambudkar SV, Gottesman MM, Kimchi-Sarfaty C. Silent (synonymous) SNPs: should we care about them? Methods Mol Biol. 2009; 578: 23-39.

KNIGHT JC. Regulatory polymorphisms underlying complex disease traits. J Mol Med. 2005 Feb; 83 (2): 97-109.

FEUK L, Carson AR, Scherer SW. Structural variation in the human genome. Nat Rev Genet 2006 Feb; 7 (2): 85-97.

RONAGHhI M, Langaee T. Single nucleotide polymorphism: discovery, detection and analysis. Perzonalized medicine. 2005; 2 (2): 111-125.

KNIGHT JC. Functional implications of genetic variation in non-coding DNA for disease susceptibility and gene regulation. Clin Sci (Lond) 2003 May; 104 (5): 493-501.

KNIGHT JC, Udalova I, Hill AV, Greenwood BM, Peshu N, Marsh K, Kwiatkowski D. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet. 1999 Jun; 22 (2): 145-150.

MIGNONE F, Gissi C, Liuni S, Pesole G. Untranslated regions of mRNAs.

Genome Biol. 2002; 3 (3): review0004.1-0004.10

CAZZOlA M, Skoda RC. Translational pathophysiology: a novel molecular mechanism of human disease. Blood. 2000 Jun 1; 95 (11): 3280-3288.

LYNCH KW, Weiss A. A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer. J Biol Chem. 2001 Jun 29; 276 (26):24341-24347.

ELVIDGE G. Microarray expression technology: from start to finish.Pharmacogenomics 2006 Jan; 7 (1): 123-134.

VELCUlESCU VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science. 1995 Oct 20; 270 (5235); 484-487.

KURELLA M, Hsiao LL, Yoshida T, Randall JD, Chow G, Sarang SS, et al. DNA microarray analysis of complex biologic processes. J Am Soc Nephrol.2001 May; 12 (5): 1072-1078.

LEE C, Roy M. Analysis of alternative splicing with microarrays: successes and challenges. Genome Biology. 2004; 5 (7):231-234.

BEN-DOV C, Hartmann B, Lundgren J, Valcárcel J. Genome-wide analysis of alternative pre-mRNA splicing. J Biol Chem. 2008 Jan 18; 283 (3); 1229-1233.

JOHNSON JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD, et al. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science. 2003 Dec 19; 302 (5653): 2141-2144.

International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Natur.e 2001 Feb 15; 409 (6822):860-921.38.

Modrek B, Lee CJ. A genomic view of alternative splicing. Nat Genet. 2002 Jan; 30 (1):13-19.

LOPEZ-BIGAS N, Audit B, Ouzounis C, Parra G, Guigó R. Are splicing mutations the most frequent cause of hereditary disease? FEBS Letters. 2005 Mar 28; 579 (9)

STEEMERS FJ, Gunderson KL. Illumina Inc. Pharmacogenomics. 2005 Oct; 6 (7): 777-782.

The World Health Organization. The World Health Report 2002–Reducing Risks, Promoting Healthy Life (World Health Organization, 2002).

LEVYD, DeStefano AL, Larson MG, O´Donnell CJ, Lifton RP, Gavras H, et al. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension 2000 Oct; 36 (4): 477-483.

RAFIQ S, Anand S, Roberts R. Genome-wide association studies of hypertension: have they been fruitful?. J Cardiovasc Transl Res. 2010 Jun; 3 (3): 189-196.

NEWTON-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet. 2009 Jun; 41 (6): 666-676.

LEVY D, Ehret GB, Rice K, Verwoert GC, Launer LJ, dehghan A, et al.

Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009 Jun; 41 (6): 677-687.

MARQUES FZ, Campain AE, Yang YH, Morris BJ. Meta-analysis of genome-wide gene expression differences in onset and maintenance phases of genetic hypertension. Hypertension. 2010 Aug; 56 (2): 319-324.

CHON H, Gaillard CA, van der Meijden BB, Dijstelbloem HM, Kraaijenhagen RJ, van Leenen D, et al. Broadly altered gene expression in blood leukocytes in essential hypertension is absent during treatment. Hypertension. 2004 May; 43 (5): 947-951.

TIMOFEEVA AV, Goryunova LE, Khaspekov GL, Kovalevskii DA, Scamrov AV, Bulkina OS, et al. Altered gene expression pattern in peripheral blood leukocytes from patients with arterial hypertension. Ann NY Acad Sci 2006 Dec; 1091: 319-335.

TIMOFEEVA AV, Goryunova LE, Khaspekov GL, Il´inskaia OP, Sirotkin VN, Andreeva ER et al. Comparative transcriptome analysis of human aorta atherosclerotic lesions and peripheral blood leukocytes from essential hypertension patients. Kardiologiia. 2009; 49 (9): 27-38.

JAMES WP. The epidemiology of obesity: the size of the problem. J Intern Med. 2008 Apr; 263 (4):336-352.

REDINGER R. The prevalence and etiology of nongenetic obesity and associated disorders. South Med J. 2008 Apr; 101 (104): 395-399.

FRAYN KN. Adipose tissue and the insulin resistance syndrome. Proc Nutr Soc. 2001 Aug; 60 (3): 375-380.

PAUZOVA Z, Gossard F, Gaudet D, tremblay J, Kotchen TA, Cowley AW, et al. Heritability estimates of obesity measures in siblings with and without hypertension. Hypertension. 2001 Jul; 38 (1): 41-47.

WARDLe J, Carnell S, Haworth CM, Plomin R. Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment. Am J Clin Nutr 2008 Feb; 87 (2): 398-404.

HINDLE AK, koury J, McCaffrey T, Fu SW, Brody F. Dysregulation of gene expression within the peroxisome proliferation activated receptor pathway in morbidly obese patients. Surg Endosc 2009; 23: 1292-1297.

MAClAREN RE, Cui W, lu H, Simard S, Cianflone K. Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects. BMC Med Genomics 2010; 3: 3.

GHOSH S, Dent R, Harper ME, Gorman SA, Stuart JS, McPherson R. Gene expression profiling in whole blood identifies distinct biological pathways associated with obesity. BMC Med Genomics 2010; 3: 56

Rodríguez-Acebes S, Palacios N, Botella-Carretero JI, Olea N, Crespo L, Peromingo R, et al. Gene expression profiling of subcutaneous adipose tissue in morbid obesity using a focused microarray: distinct expression of cell-cycle- and differentiation-related genes. BMC Med Genomics 2010; 3: 61.

ZIMMET P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemiology. Nature 414; 782-787.

SIMPSON RW, Shaw JE, Zimmet PZ. The prevention of type 2 diabetes–lifestyle change or pharmacotherapy? A challenge for the 21st century. Diabetes Res Clin Pract 2003; 59: 165–180.

SHUlMAN GI.Cellular mechanisms of insulin resistance. J Clin Invest 2000; 106:171–176.

PEHLING G, Tessari P, Gerich JE, Haymond MW, Service FJ, et al. Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy. J Clin Invest 1984; 74: 985–991.

MUOIO DM, Newgard CB. Molecular and metabolic mechanisms of insulin resistance and [beta]-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9: 193–205.

POUlSEN P, Kyvik KO, Vaag A, Beck-Nielsen H. Heritability of type II (non- insulin-dependent) diabetes mellitus and abnormal glucose tolerance-a population-based twin study. Diabetologia 1999; 42, 139–145.

SREEKUMAR R, Halvatsiotis P, Schimke JC, Nair KS. Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 2002; 51: 1913-1920.

PATTI ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistence and diabetes: potential role of PGC1 and NFR1. Proc Nat Acad Sci USA 2003; 100: 8466-8471.

MOOTHA VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1 alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267-273.

STENTZ FB, Kitabchi AE. Transcriptome and proteome expressions involved in insulin resistence in muscle and activated T-lymphocytes of patients with type 2 diabetes. Genomics Proteomics Bioinformatics 2007; 5: 216-235.

YANG YL, Xiang RL, Yang C, Liu XJ, Shen WJ, Zuo J, et al. Gene expression profile of human skeletal muscle and adipose tissue of Chinese Han patients with type 2 diabetes mellitus. Biomed Environ Sci 2009; 22: 359-368.

PAlSGAAR J, Brøns C, Friedrichsen M, Dominguez H, Jensen M, Storgaard H, et al. Gene expression in skeletal muscle biopsies from people with type 2

diabetes and relatives: differential regulation of insulin signaling pathways. Plos One 2009; 4: e6575.

MARSELLI L, Thorne J, Dahiya S, Sgroi DC, Sharma A, Bonner-Weir S, et al. Gene expression profiles of Beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes. Plos One 2010; 5: e11499.

WEYAND CM, Seyler TM, Goronzy JJ. B cells in rheumatoid synovitis. Arthritis Res Ther 2005; 7 Suppl 3: S9-S12.

lUNDy SK, Sarkar S, Tesmer LA, Fox DA. Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res Ther 2007; 9: 202.

MCINNES IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007; 7; 429-442.

MACGREGOR AJ, Snieder H, Rigby AS, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins . Arthritis Rheum 2000; 43: 30-37.

BOVIN LF, Rieneck K, Workman C, Nielsen H, Sørensen SF, Skjødt H, et al. Blood cell gene expression profiling in rheumatoid arthritis. Discriminative genes and effect of rheumatoid factor. Immunol Lett 2004; 93: 217-226.

BATlIWAllA FM, Baechler EC, Xiao X, Li W, Balasubramanian S, Khalili H, et al. Peripheral blood gene expression profiling in rheumatoid arthritis. Genes Immun 2005; 6: 388-397.

LINDBERG J, af Klint E, Catrina AI, Nilsson P, Klareskog L, Ulfgren AK, et al. Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients. Arthritis Res Ther 2006; 8: R179.

LEQUERRE T, Gauthier-Jauneau AC, Bansard C, Derambure C, Hiron M, Vittecoq O, et al. Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis. Arthritis Res Ther 2006; 8: R105.

GALLIGAN CL, Baig E, Bykerk V, Keystone EC, Fish EN. Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: correlates with disease activity. Genes Immun 2007; 8: 480-491.

JULIA A, Erra A, Palacio C, Tomas C, Sans X, Barceló P, et al. An eight-gene blood expression profile predicts the response to infliximab in rheumatoid arthritis. Plos One 2009; 4: e7556.

BADOT V, Galant C, Nzeusseu Toukap A, Theate I, Maudoux AL, Van den Eynde BJ, et al. Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis. Arthritis Res Ther 2009; 11: R57.

CHEN G, Goeddel DV. TNF-R1 signaling: a beutiful pathway. Science 2002; 296: 1634-1635.

RAGhAV SK, Gupta B, Agrawal C, Chaturvedi VP, Das HR. Expression of TNF-alpha and related signaling molecules in the peripheral blood mononuclear cells of rheumatoid arthritis patients. Mediators Inflamm 2006; 2006; 12682.

WAlTHER C, Mann M. Mass spectrometry-based proteomics in cell biology. J. Cell Biol. 2010; 190:491-500.

PANDO V, Ferreira C. Proteómica: hacia el entendimiento del lenguaje de las proteínas. Biotecnología. 2007; 14: 97-108

HOCHSTRASSER D, Sanchez J, Appel R. Proteomics and its trends facing nature´s complexity. Proteomics. 2002; 2: 807-812.

VERRILS N. Clinical proteomics: Present and future prospects. Clin Biochem Rev. 2006; 27: 99-116.

WIlKINS M, Sanchez J, Gooley A, Appel R, Humphery-Smith I, Hochstrasser D, et al. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev. 1996; 13:19-50.

APWEILER R, Aslanidis C, Deufel T, Gerstner A, Hansen J, Hochstrasser D, et al. Approaching clinical proteomics: Current state and future fields of application in cellular proteomics. Cytometry. 2009; 75:816-832.

KRUSE U, Bantscheff M, Drewes G, Hopf C. Chemical and Pathway Proteomics. Moll.Cell.Proteomics. 2008; 7:1887-1901.

ANDERSEN J, Mann M. Organellar proteomics: turning inventories into insights. EMBO. 2006; 7:874-879.

IMAI Z, Koshiyama A, Nakata K. Towards clinical proteomics analysis. Biomed chromatogr. 2011; 25: 59-64.

TATE E W. Recent advances in chemical proteomics: exploring the postranslational proteome. J Chem Biol. 2008; 1:17–26.

GRANVOGl B, Plöscher M, Eichacker L A. Sample preparation by in-gel digestion for mass spectrometry-based proteomics. Anal Bioanal Chem. 2007; 389:991–1002.

PANDO V, Lanz H, La importancia de la proteómica en la salud pública. Salud pública de México. 2009. 51:386-394.

FENG X, Lui X, Luo Q, Liu Bi-Feng. Mass spectometry in systems biology: an overview. Mass Spec Rev. 2008; 27:635-660.

AEBERSOlD R, Mann M. Mass spectrometry-based proteomics. Nature. 2003. 422:198-207.

WERNER T. Proteomics and regulomics: The yin and yang of function a genomics. Mass Spec Rev. 2004; 23:25-33.

Hebestreit H. Proteomics: a holistic analysis of nature´s proteins. Current opinion in pharmacology. 2001; 1:513-520.

BEAlE, G. (1993). The Discovery of Mustard Gas Mutagenesis by Auerbach and Robson in 1941. Genetics 134 (2): 393–399.

MULLER, H. J. (1927). Artificial Transmutation of the Gene. Science 66 (1699): 84–87.

CROW, J. F.; Abrahamson, S. (1997). Seventy Years Ago: Mutation Becomes Experimental. Genetics 147 (4): 1491–1496.

STADlER, L. J. (1928). Mutations in Barley Induced by X-Rays and Radium. Science 68 (1756): 186–187.

STADlER, L. J.; Sprague, G. F. (1936). Genetic Effects of Ultra-Violet Radiation in Maize. I. Unfiltered Radiation. Proc Natl Acad Sci U S A. 22 (10): 572- 578.

AUERBACH Ch., Robson, J. M., Carr, J. G.(1947) Chemical Production of Mutations, Science 105: 243-247.

BROWN, J. R.; Thornton, J. L. (1957). Percivall Pott (1714-1788) and Chimney Sweepers’ Cancer of the Scrotum. British journal of industrial medicine 14 (1): 68–70.

YAMAGAWA K., Ichikawa K. (1915). Experimentelle Studie ueber die Pathogenese der Epithel geschwuelste. Mitteilungen aus der medizinischen Fakultät der Kaiserlichen Universität zu Tokyo 15: 295–344.

LUCH A. (2005). Nature and nurture - lessons from chemical carcinogenesis. Nat Rev Cancer. 5 (2): 113-125.

LENGAUER, C., Kinzler, K. W., Vogelstein, B. (1998). Genetic instabilities in human cáncer. Nature 396: 643-649.

ORR-WeAVeR, T. L., Weinberg, R. A. (1998). A checkpoint on the road to cáncer.Nature 392: 223-224.

PONDER, B. A. (2001). Cancer genetics. Nature 441: 336-341.

EPSTEIN, C. J. (1988). Mechanisms of the effects of aneuploidy in mammals. Annual Review of Genetics 22: 51-75.

COHEN, J. (2002). Sorting out chromosome errors. Science 296: 2164-2166.

PATTTRSON, D. (1987). The causes of Down síndrome. Scientific American 257 (2): 52-60.

LEJEUNE J., Lafourcade J., Berger R., Vialatte J., Boeswillwald M., Seringe

P. Turpin R. (1963). 3 cases of partial deletion of the short arm of a 5 chromosome. C. R. Hebd Seances Acad Sci. 257: 3098-3102.

RABBITTS, T.H. (1994). Chromosomal translocations in humans cancers. Nature 372: 143-149.

ROWLEY, J. D. (1998). The critical role of chromosome translocations in human leukemias. Annual Review of Genetics 32: 495-519.

SANCHEZ-GARCÍA, I. (1997). Consequences of chromosome abnormalities in tumor development. Annual Review of Genetics 31: 429-453.

VERKERK, A. J., Pieretti, M., Sutcliffe J. S., Fu Y.-H., Kuhl D. P., Pizzuti A., Reiner O., Richards S., Victoria M. F., Zhang F. P., Eussen B. E., van Ommen G.-J., Blonden L. A., Riggins G. J, Chastain J. L., Kunst C. B., Galjaard H., Caskey C. T., Nelson D. L., Oostra B. A., Warren S. T.(1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65 (5): 905-914.

YU, S., Mulley, J. Loesch, D., Turner G., Donnelly, A. Gedeon, A., Hillen, D., Kremer, E., Lynch, M., Pritchard, M., Sunderland, G. R., Richards, R. I. (1992). Fragile-X syndrome: unique genetics of the heritable unstable element. American Journal of Human Genetics 50: 968-980.

ASHLEY-KOCH, A. E., Robinson H., Glicksman A. E., Nolin S. L., Schwartz C. E., Brown W. T., Turner G., Sherman S. L. (1997). Examination of factors associated with instability of the FMR1 CGG repeat. Am. J. Hum. Genet. 63: 776-785.

SINDEN, R. R. (1999). Biological implications of DNA structures associated with disease-causing triplet repeats. American Journal of Human Genetics 64: 346-353.

GOODMAN, M. F. (1995). DNA models: mutations caught in the act. Nature 378: 237-238.

CADENAS E. (1989). Biochemistry of oxygen toxicity. Annu Rev Biochem. 58: 79-110.

COMPORTI M. (1989). Three models of free radical-induced cell injury. Chem Biol Interact. 72 (1-2): 1-56.

PUEYO, C., Ariza, R. R. (1993). Role of rective oxygen species in the mutagenicity of complex mixture of plant origen. En “DNA and freeradicals”, U. Halliwell and O. I. Aruoma (eds.), Vol. 14, pp: 275-279, Ellis Horwood, Sacramento, London.

BECKER, M. M., Wang, Z. (1989). Origin of ultraviolet damage in DNA. J. Mol. Biol. 210: 429-438.

PIERCE, B. A. (2009). Genética: un enfoque conceptual. Editorial médica panamericana. Cap. 13, pp: 337-340.

BEADLE G. W., Tatum E. L. (1941). Genetic control of biochemical reactions in neurospora. Proc Natl Acad Sci U S A. 27 (11): 499-506.

NEEL, J. V., Satoh, C., Hamilton, H. B., Otake, M. Goriki, K., Kageoka, T., Fujita, M., Neriishi, S., Asawaka, J. (1980). Search for mutations affecting protein structure in children of atomic bomb survivors: preliminary report. Proceeding of the National Academy of Sciences of the United States of America. 77: 4221-4225.

SCHULL, W. J., Otake, M., Neel, J. V. (1981). Genetic effects of the atomics bombs: a reappraisal. Science 213: 1220-1227.

DUBROVA, Y. E., Nesterov, V. N., Krouchinsky, N. G., Ostapenko, V. A., Neumann, R., Neil, D. L., Jeffreys, A. J. (1996). Human minisatellite mutation rate after the Chernobyl accident. Nature 380: 683-686.

RUSSEI W. L. (1951). X-ray-induced mutations in mice, Quant. Biol. 16: 327- 336.

AMES, B. N., McCann, J., Yamasaki, E. (1975). Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res. 31 (6): 347-364. 36.

Ames B. N, Kammen H. O., Yamasaki E. (1975). Hair dyes are mutagenic: identification of a variety of mutagenic ingredients. Proc Natl Acad Sci U S A. 72 (6): 2423-2427.

GABRIDGe, M. G., Legator, M. S. (1969). A host-mediated microbial assay for the detection of mutagenic compounds. Proc Soc Exp Biol Med. 130 (3): 831- 834.

MAllING, H. V., De Serres,F. J. (1971). Hydroxylamine-induced purple adenine (ad-3) mutants in Neurospora crassa. I. Characterization of mutants by genetic tests. Mutat Res. 12 (1): 35-46.

RUIZ-VázQUez, R., Pueyo, C., Cerdá-Olmedo, E. (1978). A mutagen assay detecting forward mutations in an arabinose-sensitive strain of Salmonella typhimurium. Mutat. Res. 54 (2): 121-129.

MCCANN J, Choi E, Yamasaki E, Ames B. N. (1975). Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc Natl Acad Sci U S A. 72 (12): 5135-5139.

TANAKA, K., Wood, R. D. (1994). Xeroderma pigmentosum and nucleotide excision repair. Trends in Biochemical Science 19: 84-86.

ASHBY J., Tennant R. W. (1988). Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP. Mutat Res. 204 (1): 17-115.

ASHBy J., Tennant R. W. (1994). Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat Res. 257(3): 229-306. Erratum in: Mutat Res 317 (2): 175.

QUILLARDET, Ph., Huisman, O., D´ari, R., Hofnung, M. (1982) SOS chromotest, a direct assay of induction of an SOS function in Escherichia coli K-12 to measure genotoxicity. Proc. NatL Acad. Sci. 79: 5971-5975.

BOMBARDIER, M., Bermingham, N., Legault, R., Fouquet, A. (2001). Evaluation of an SOS-Chromotest-based approach for the isolation and detection of sediment-associated genotoxins. Chemosphere. 42 (8): 931-944.

Kelly, C. M., Latimer, J. J. (2004). Unscheduled DNA synthesis: a functional assay for global genomic nucleotide excision repair. Molecular Toxicology Protocols 291: 303-320.

ASHBY J, Richardson C. R. (1985). Tabulation and assessment of 113 human surveillance cytogenetic studies conducted between 1965 and 1984. Mutat Res. 154 (2):111-33.

KIlIAN D. J., Picciano D. J., Jacobson C. B. (1975). Industrial monitoring: a cytogenetic approach. Ann N Y Acad Sci. 269: 4-11.

BECKMAN G, Beckman L, Nordenson I.(1977). Chromosome aberrations in workers exposed to arsenic. Environ Health Perspect.19: 145-6.

NORDENSON I, Beckman G, Beckman L, Nordström S. (1978). Occupational and environmental risks in and around a smelter in northern Sweden. II. Chromosomal aberrations in workers exposed to arsenic. Hereditas 88 (1): 47-50.

NORDSTRÖM S, Beckman L, Nordenson I. (1978). Occupational and environmental risks in and around a smelter in northern Sweden. III. Frequencies of spontaneous abortion. Hereditas. 188 (1): 51-54.

NORDSTRÖM S, Beckman L, Nordenson I.(1978). Occupational and environmental risks in and around a smelter in northern Sweden. I. Variations in birth weight. Hereditas 88(1): 43-46.

FREDGA, K., Reitalu, J., Berlin, M. (1979). Chromosome studies in workers exposed to benzene. En “Genetic damage in man caused by environmental agents”, K. Berg (ed.), pp:187-203, Academic Press, New York.

VENTER J.C., Adams M.D., Myers E.W., et al. The sequence of the human genome. Science. 2001; 291: 1304- 51.

WATSON J.D. “The Human Genome Pro j e c t : Past, Present and Future”.Science. 1990; 248: 44-48.

HOULE D., Govindaraju D.R., Omholt S. Phenomics: the next challenge. Nature Rev. Genet. 2010; 11:855-66.

FERNANDEz-RICAUD L., Warringer J., Ericson E., Glaab K., Davidsson P., Nilsson F., et al. PROPHECY—a yeast phenome database, update 2006. Nucleic Acids Res. 2006; 35:463-67.

TIAN C., Chikayama E., Tsuboi Y., Kuromori T., Shinozaki K., Kikuchi J., et al. Top-down Phenomics of Arabidopsis thaliana: Metabolic profiling by one- and two-dimensional nuclear magneticresonance spectroscopy and transcriptome analysis of albino mutants.J. Biol. Chem.2007; 282(25):18532-41.

VENKATESh B., Kirkness E.F., Loh Y.H., Halpern A.L., Lee A.P., Johnson J, Dandona N, et al. Survey sequencing and comparative analysis of the elephant shark (Callorhinchus milii) genome. PLoS Bio. 2007; 5(4): 932-44.

JAILlON O., Aury J.M., Brunet F., Petit J.L., Stange-Thomann N., et al. Genome duplication in the teleost fish Tetraodon nigroviridis reveals the early vertebrate proto-karyotype. Nature. 2004; 431: 946–57.

ChHURCH D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., et al. Lineage-Specific biology revealed by a finished genome assembly of the mouse. PLos Bio. 2009; 7(5): 1-16.

MIKKELSEN T.S., Hillier L.W., Eichler E.E., Zody M.C., Jaffe D.B., Yang S., et al. The Chimpanzee Sequencing and Analysis Consortium. Nature. 2005; 437: 69-87.

BILDER R.M., Sabb F.W., Cannon T.D., London E.D., Jentsch J.D., Stott Parker D., et al. Phenomics: the systematic study of phenotypes on a genome-wide scale. Neuroscience. 2009; 164: 30–42.

KOKEL D., Peterson R.T. Chemobehavioural phenomics and behaviour- based psychiatric drug discovery in the zebrafish. Briefings in functional genomics and proteomics. 2008; 7 (6): 483-90.

FREIMER N., Sabatti C. “The human phenome project”. Nature Rev Genet. 2003; 34: 15-21.

GOVINDARAJU D.R., Cupples L.A., Kannel W.B., O´Donnel C.J, Atwood L.D., D’Agostino R.B., et al. Genetics of the Framingham Heart Study population. Adv Genet. 2008; 62: 33-65

BILDER R.M., Sabb F.W., Stott Parker D., Kalar D, Chu W.W., Fox J., Cognitive ontologies for neuropsychiatric phenomics research. Cognitive Neuropsychiatry. 2009; 14 (4/5), 419-50

East A. Mendelian interpretation of variation that is apparently continuous. American Naturalist 1910; 44: 65-82 East. Studies on size inheritance in Nicotiana Genetics 1916;1:164

YUANFANG G., Ackert-Bicknell C., Kell B., Troyanskaya O., Hibbs M. Functional Genomics Complements Quantitative Genetics in Identifying Disease- Gene Associations. 2010; 6(11): 1-11.

Mapping Environment-Specific Quantitative Trait Loci. Genetics. 2010; 186(3): 1053-1066.

BRADSHAW H.D., Otto K.G., Frewen, B.E., McKay J., Schemske D. W. Quantitative Trait Loci Affecting Differences in Floral Morphology Between Two Species of Monkeyflower (Mimulus).Genetics. 1998; 149:367–382

Bell A.E. Heritability in retrospect.1977; The Journal of Heredity 68:297- 300.

AKERBERG E. Nilsson-Ehle and the development of plant breeding at Svalof during the period 1900-1915. 1986, Hereditas. 105; 1-5.

LYNCH M., Walsh B. Genetics and analysis of quantitative traits.1998;Sunderland, M.A: Sinauer.

HARTl D.,L., Jones E.W. Genetics: Principles and analysis.1998. Jones and Barlett Publishers. Inc.

RUSELL, P. Genetics a Molecular Approach. 2010. Pearson Education.

JAIN, H.K., Kharkwal M.C., Plant Breeding Mendelian and Molecular Approaches.2004. Narosa Publishing House.

PARAN I., y Zamir D. Quantitative traits in plants: beyond the QTL. 2003. TRENDS in Genetics. Vol.19 No.6; 303-06.

COSTER. A., Bastiaansen J.M., Calus M.L., Van Arendonk J.A., Bovenhuis,

H. Sensitivity of methods for estimating breeding values using genetic markers to the number of QTL and distribution of QTL variance. 2010. Genetics Selection Evolution 42:9

GODDARD,M.E., Hayer,B.J.. Genomic selection. 2007. Journal of Animal Breeding and Genetics. 124(6):323-30.

ROBIN C., Lyman R.F., Long A.D., Langley C.H. y MacKay, T.C. hairy: A quantitative trait locus for Drosophila sensory bristle number. 2002. Genetics 162:155-64.

MORGAN, T.H. Sex-linked inheritance in Drosophila. Science. 1910. 32:120-122.

MARKERT C.L., Moller F., Multiple forms of enzymes; tissue, ontogenic, and species-specific patterns. 1959. Proceeding of the National Academic of Sciences. USA. 45:753-63.

TANKSLEy,S.D., Orton, T.J. Isozymes in Plant Genetics and Breeding. Parts 1A y 1B.1983. Elsevier, Amsterdam, Netherlands.

BOTSTEIN D., White, R.L., Skolnick M., Davis R.W. Construction of a genetic linkage map in man using restriction fragment length polymorphism.1980. American Journal of Human Genetics. 32(3):314-31.

MULLIS K., Faloona F. Specific synthesis of DNA in vitro via a polymerase catalyzed chain reaction. Methods in Enzymology. 1987. 155: 335-51.

MULLIS K., Faloona F., Scharf S., Saiki R.K., Horn G., Erlich H. Specific enzymatic amplification of DNA in vitro: The polymerase chain reaction. 1986. Cold Spring Harbor Symposium Quantitative Biology. 51:263.

BROWN T.A. Genomes 3. 2007. Garland Science Publishing.

GRIFFITHS A.J., Gelbart W.M., Miller J.H. Modern Analysis Genetics. 1999. WPaterson A.H., Lander E.S., Hewitt J.D., Peterson S., Lincoln S.E., Tanksley S.D. Resolution of quantitative traits into Mendelian factors by using a complete RFLP linkage map. 1988. Nature, 335:721-26.

PATERSON A.H., Bowers J.E. Comparative genomics Plant chromosome. 2000.

Plant Cell, 12:1523-39.

HUlBERT SH., Richter TE., Axtell JD., Bennetzen J.L. Genetics mapping and characterization of sorghum and related crops by means of maize DNA probes.1990. Proceedings of National Academic of Science. USA, 87:4251- 55.

AHN S., Tanksley S.D. Comparative linkage maps of the rice and maize genomes. 1993. Proceedings of the National Academic of Science. USA, 90:7980-84.

AHN S., Anderson JA., Sorrells M.E., Tanksley SD. Homeologous relationships of rice, wheat, and maize chromosomes. 1993. Molecular Genetics and Genomics. 241:483-90.

KURATA N., Moore G., Nagamura Y., Foote T., Yano M., Minobe Y., et al. Conservation of genome structure between rice and wheat. 1994. Biotechnology, 12:276-78.

BeNNETZEN JL., Freeling M. Grasses as a single genetic system: genome composition, clonearity and compatibility. 1993. Trends Genetics.9: 259- 61.

KOLE C., Quijada P., Michaels AD., Amasino R., Osborn TC. Evidence for homologu of flowering time genes VFR2 from Brassica rapa and FLC from Arabidopsis thaliana. 2001. Theorical and applied genetics. 102:425- 430.

DAHM R. El descubrimiento del DNA, investigación y ciencia. 2008; No. 385, 77-85.

BUTLER J.M. Fundamentals of Forensic DNA Typing. Elsevier Academic Press, San Diego. 2010.

BOOM R., Sol, C.J., Salimans, M.M., Jansen, C.L., P.M. Wertheim-van D., and Noordaa J. V., Rapid and simple method for purification of nucleic.Acids.J Clin Microbiol.1990; 28:495-03.

WAISH P.S, Metzger D,A, Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques. 1991; 10(4):506-13.

GIll P., Jeffreys A.J., Werrett D.J. Forensic application of DNA ‘fingerprints’. Nature. 1985; 318, 577-79.

BUTLER J.M. Genetics and Genomics of Core STR Loci Used in Human Identity Testing, J Forensic Sci. 2006; Vol. 51, No. 2.

JOBLING M.A. and Gill P. Encoded evidence: DNA in forensic analysis. Nature Review Genetics.2004; 5, 739-51.

WyMAN A. and White R. A highly polymorphic locus in human DNA, Proc.Natl. Acad. Sci. 1980; 77: 6754-58.

JEFFREYS A. J., Wilson V. & Thein, S. L. Hypervariable ‘minisatellite’ regions in human DNA. Nature. 1985; 314, 67–73.

JEFFREYS A. J., Wilson V. & Thein, S. L. Individual-specific ‘fingerprints’ of human DNA. Nature.1985; 316, 76–79.

BRETTEll T.A., Butler J.M., Saferstein, R. Forensic science. Anal.Chem. 2005; 77: 3839-3860.

RANA Saad R. Discovery, development, and current applications of DNA identity testing. Proc (Bayl Univ Med Cent). 2005; 18(2): 130–33.

KASHYAP V.K., Sitalaximi T., Chattopadhyay P., Trivedi R. DNA Profiling Technologies in Forensic Analysis, Int J Hum Genet. 2004; 4(1): 11-30.

BUTlER J.M. Forensic DNA Typing “Biology, Technology, and Genetics of STR Markers”, Elservier Academic Press. Second Edition, USA. 2005.

COTTON E.A., Allsop R.F., Guest J.L., Frazier R.R., Koumi P., Callow I.P., Seager

A. and Sparkes R.L. Validation of the AMPFlSTR SGM plus system for use in forensic casework. Forensic Sci. Int. 2000;112, 151–61.

DUEWER D.L., Kline M.C., Redman J.W., Butler J.M. NIST Mixed Stain Study #3: signal intensity balance in commercial short tandem repeat multiplexes, Anal. Chem. 2004; 76: 6928-34.

Innocence Project [en linea]. Disponible en [acceso: 20 marzo 2011].

VALLONW P.M., Decker A.E., Butler, J.M. Allele frequencies for 70 autosomal SNP loci with U.S. Caucasian, African American, and Hispanic samples. Forensic Sci. Int. 2005; 149: 279-86.

BIESECKER L.G., Bailey-Wilson J.E., Ballantyne J., Baum H., Bieber F.R., Brenner C., et al. DNA identifications after the 9/11 World Trade Center attack. Science.2005; 310:1122-23.

BUTLER J.M., Shen Y., McCord, B. R. The development of reduced size STR amplicons as tools for analysis of degraded DNA. J. Forensic Sci. 2003; 48, 1054–64.

DIXON L.A., Dobbins A.E., Pulker H.K., Butler J.M., Vallone P.M., Coble M.D., et al,. Analysis of artificially degraded DNA using STRs and SNPs--results of a collaborative European (EDNAP) exercise.Forensic Sci Int. 2006; 1;164(1):33-44.

RANGEl-VIllAlOBOS H. La historia del hombre descrita por el cromosoma Y; en: Historia Biológica del Hombre en América. Coordinador Gonzalez-MartínA. Universidad Autónoma del Estado de Hidalgo, Hidalgo, México. 2006.

SheWAle J. G., Sikka S. C., Schneida E. & Sinha S. K. DNA profiling of azoospermic semen samples from vasectomized males by using Y-PLEX 6 amplification kit. J. Forensic Sci. 2003; 48, 127–29.

SAGAN L. On the origin of mitosing cells J Theor Biol. 1967; 14(3):255-74.

IVANOV P.L., Wadhams M.J., Roby R.K., Holland M.M., Weedn V.W., Parsons

T.J. Mitochondrial DNA sequence heteroplasmy in the Grand Duke of Russia Georgij Romanov establishes the authenticity of the remains of Tsar Nicholas II. Nature Genet. 1996; 12, 417–20.

YANG D.Y., Speller C.F., Technical Tips for Obtaining Reliable DNA Identification of Historic Human Remains, Technical Briefs In historical archaeology. 2006. 1: 11–15.

SHRIVER M.D., Smith M.W., Jin L., Marcini A., Akey J.M., Deka R., et al. Ethnic- affiliation estimation by use of population-specific DNA markers. Am. J. Hum. Genet. 1997; 60, 957–64.

COLLINS-SChRAMM H.E., Phillips C.M., Operario D.J., Lee J.S., Weber J.L., Hanson R.L., et al. Ethnic-difference markers for use in mapping by admixture linkage disequilibrium. Am. J. Hum. Genet. 2002; 70, 737–50.

lIU F., Van D.K., Vingerling J.R., Hofman A., Uitterlinden A.G, Cecile A., et al. Eye color and the prediction of complex phenotypes from genotypes. Current Biology. 2009; 19(5):R192-3.

BRANICKI W., Kupiec T. & Pawlowski R. Validation of cytochrome b sequence analysis as a method of species identification. J. Forensic. Sci. 2003; 48, 83–87.

International Consortium for the Barcode of Life [en linea]. Disponible en [acceso: 20 marzo 2011].

YAO H., Song J., Liu C., Luo K., Han J., Li Y., et al. Use of ITS2 Region as the Universal DNA Barcode for Plants and Animals PLoS One. 2010; 5(10):

HSIEH H.M., Hou R.J., Tsai L.C., Wei C.S., Liu S.W., Huang L.H., et al. Linacre

A. and Lee J.C. A highly polymorphic STR locus in Cannabis sativa. Forensic Sci. Int. 2003; 131, 53–58.

YEUNG, S.H., Liu P.,. Del Bueno N.,. Greenspoon S.A., Mathies R.A.. Integrated sample cleanup-capillary electrophoresis microchip for high-performance short tandem repeat genetic analysis. Anal.Chem. 2009; 81:210- 17.

DIVNe A.M., Edlund H., and Allen M., Forensic analysis of autosomal STR markers using Pyrosequencing. Forensic Sci Int Genet. 2010;4(2):122-29.

FIERER N., Lauber C.L., Zhou N., McDonald D., Costello E.K., Knight R. Forensic identification using skin bacterial communities. Proc Natl Acad. 2010; 107(14):6477-81.

BRENIG B., Beck J., Schütz E., Shotgun metagenomics of biological stains using ultra-deep DNA sequencing. Forensic Sci Int Genet. 2010; 4(4):228-3138.

Budowle B., Van D.A. Extracting evidence from forensic DNA analyses: future molecular biology directions. Biotech. 2009; 46: 339–50.

European Bioinformatics Institute E. What is Bioinformatics [Internet]. The gnomic era. 2012 [citado 2012 mar 2]. Disponible a partir de:http://www.

KOhleR S, Bauer S, Mungall C, Carletti G, Smith C, Schofield P, et al.

Improving ontologies by automatic reasoning and evaluation of logical definitions. BMC Bioinformatics [Internet]. 2011;12(1):418. Disponible a partir de:

BANGA J. Optimization in computational systems biology. BMC Systems Biology [Internet]. 2008;2(1):47. Disponible a partir de: http://www.biomedcentral. com/1752-0509/2/47

VAN GEIT W, De Schutter E, Achard P. Automated neuron model optimization techniques: a review. Biological cibernetics [Internet]. 2008 [citado 2012 mar 2];99(4-5):241–51. Disponible a partir de: http://www.springerlink. com/content/t34178u60n5w162g/

RAJAPAKSE JC, Schmidt B, Volkert G, editores. Pattern Recognition in bioinformatics [Internet].2007 [citado 2012 mar 1]. Disponible a partir de: tion+retrieval/book/978-3-540-75285-1

TRUONG C, Groeneveld L, Morgenstern B, Groeneveld E. MolabIS - An integrated information system for storing and managing molecular genetics data. BMC Bioinformatics [Internet]. 2011;12(1):425. Disponible a partir de:

AYYASh M, Tamimi H, Ashhab Y. Developing a Powerful In Silico Tool for the Discovery of Novel Caspase-3 Substrates: A Preliminary Screening of the Human Proteome. BMC Bioinformatics [Internet]. 2012;13(1):14.

Disponible a partir de:

LYMAN P, Varian HR. How Much Information, 2003 [Internet].2003. Disponible a partir de: info-2003/

BENSON DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW. GenBank. Nucleic Acids Res. [Internet]. 2011;39 (Database issue),:D32–D37. Disponible a partir de: 10.

National Center for Biotechnology Information, NCBI.Growth of GeneBank (1982-2008) [Internet]. 2009. Disponible a partir de: http://

SIVA-KIRAN R.R., Setty M.V.N., Hanumatha-Rao G. Bioinformatics glossary based Database of Biological Databases: DBD. J. Biochem Tech.2009;3(1):88–90.

BRAZMA A. On the importane of standarization in life sciences. Bioinformatics review. 2001;17(2):113–4.

National Center for Biotechnology Information, NCBI. GenBank Flat File Format: Sample GeneBank Record [Internet]. 2006. Disponible a partir de:

LIPMAN D.J., Pearson W.R. Rapid and sensitive protein similarity searches.Science. 1985;227:1435–41.

ALTSCHUL S.F., Madden T.L., Schäffer A.A., Zhang J., Zhang Z., Miller W., et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl. Acids Res. 1997;25(17):3389–02.

KRÖGER P., Bry F. A computational Biology Database Digest: Data, Data Analysis, and Data Management. Distributed and Parallel Databases. 2003;13:7–42.

CERAMI E. XML for Bioinformatics.Springer; 2005.

AChARD F., Vaysseix G., Barillot E. XML, bioinformatics and data integration. Bioinformatics review. 2001;17:115–25.

GAlPERIN M.Y., Fernández-Suárez X.M. The 2012 Nucleic Acids Research Database Issue and the online Molecular Biology Database Collection. Nucleic Acids Research [Internet]. 2012;40(D1):D1–D8. Disponible a partir de: gkr1196.full

Operating Systems. Operating System Reviews (History, Facts, Versions and Screenshots) [Internet].List of Operating Systems.2012 [citado 2012 mar 8]. Disponible a partir de:

Canonical Ltd. Ubunt Documentation : Do I need anti-virus software? 2012 [citado 2012 mar 8]. Disponible a partir de: ubuntu-help/net-antivirus.html

GRANNEMAN S. Linux vs. Windows Viruses [Internet]. Linux vs. Windows Viruses. 2003 [citado 2012 mar 8]. Disponible a partir de: http://www.

Free software Foundation Inc. El sistema operativo GNU [Internet]. El sistema operativo GNU. 2010 [citado 2012 mar 8]. Disponible a partir de: http://

CORSINI A. Free Statistics - Free Statistical Software [Internet]. Free statistical software. 2012 [citado 2012 mar 8]. Disponible a partir de: http://

Biografias y vidas. Biografia de Muhammad ibn Musa al-Jwarizmi [Internet]. Biografia de Muhammad ibn Musa al-Jwarizmi. 2012 [citado 2012 mar 8]. Disponible a partir de: jwarizmi.htm

FIELD D., Tiwari B., Booth T., Houten S., Swan D., Bertrand N. et al. Open Software for biologists: from famine to feast. Nature Biotechnology .2006; 24: 801 - 03.

NERC Environmental Bioinformatics Centre. Software Packages — NERC Environmental Bioinformatics Centre. 2012.

Worlwidewords. World Wide Words: In silico. 2012. Disponible a partir de:

SRINVASA Rao V, Srinvas K. Modern drug discovery process : An in silico approach. Journal of Bioinformatics and Sequence Analysis. 2011 jun;2 (5):89 - 94.

National Center for Biotechnology Information NCBI.Cn3D Home Page [Internet]. 2011 [citado 2012 mar 12]. Disponible a partir de: http://www.

PORUBSKy PR, Meneely KM, Scott EE. Structures of Human Cytochrome P-450 2E1.Journal of Biological Chemistry [Internet]. 2008 nov 28;283(48):33698 –33707. Available a partir de: content/283/48/33698.abstract

ADOlPHE M., Parodi A.L. [Ethical issues in animal experimentation]. Bull Acad Natl Med. 2009 Nov;193(8):1803-4.

KOPALADZE R.A. [Bioethics and biomedical experiment evolution from Alkmaion to Pavlov. Dedicated to 160 years since I.P. Pavlov’s birthday]. Usp Fiziol Nauk. 2009 Jul-Sep;40(3):89-104.

PARODI A.L. [Ethical issue in animal experimentation]. Bull Acad Natl Med. 2009 Nov;193(8):1737-45; discussion 46.

REZNIKOV A.G. [Bioethical aspects of experiments on the animals]. Klin Khir. Jun(6):8-13.

SUGHRUE M.E., Mocco J., Mack W.J., Ducruet A.F., Komotar R.J., Fischbach R.L., et al. Bioethical considerations in translational research: primate stroke. Am J Bioeth. 2009 May;9(5):3-12.

STREIFFER R. Animal biotechnology and the non-identity problem. Am J Bioeth. 2008 Jun;8(6):47-8.

COLLINS K.A., Westra H.A., Dozois D.J., Stewart S.H. The validity of the brief version of the Fear of Negative Evaluation Scale. J Anxiety Disord. 2005;19(3):345-59.

JORQUI-AZOFRA M., Romeo-Casabona C.M. Some ethical aspects of xenotransplantation in light of the proposed European directive on the protection of animals used for scientific purposes. Transplant Proc. Jul- Aug;42(6):2122-5.

IZMIRLI S., Aldavood S.J., Yasar A., Phillips C.J. Introducing ethical evaluation of the use of animals in experiments in the Near East. Altern Lab Anim. Aug;38(4):331-6.

KARAPOlAT S. The use of animals in experimental studies. J Bras Pneumol.2008 Nov;34(11):989; author reply 90.

PORSOlT R.D. Historical perspective on CMS model. Psychopharmacology (Berl). 1997 Dec;134(4):363-4; discussion 71-7.

SIEGELS. Pavlovian conditioning analysis of morphine tolerance. NIDA Res Monogr. 1978(18):27-53.

AlEMAN A., Kahn R.S. Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Prog Neurobiol. 2005 Dec;77(5):283-98.

BEN-SHACHAR D., Nadri C., Karry R., Agam G. Mitochondrial complex I subunits are altered in rats with neonatal ventral hippocampal damage but not in rats exposed to oxygen restriction at neonatal age. J Mol Neurosci. 2009 Jun;38(2):143-51.

BERNSTEIN H.G., Lendeckel U., Dobrowolny H., Stauch R., Steiner J., Grecksch G., et al. Beacon-like/ubiquitin-5-like immunoreactivity is highly expressed in human hypothalamus and increased in

haloperidol-treated schizophrenics and a rat model of schizophrenia. Psychoneuroendocrinology. 2008 Apr;33(3):340-51.

GWON H.C., Choi S.H., Song Y.B., Hahn J.Y., Jeong M.H., Seong I.W., et al. Long-term clinical results and predictors of adverse outcomes after drug-eluting stent implantation for bifurcation lesions in a real-world practice: the COBIS (Coronary Bifurcation Stenting) registry. Circ J. 2010 Nov;74(11):2322-8.

BERTRAND J.B., Langlois J.B., Begou M., Volle J., Brun P., d’Amato T., et al. Longitudinal MRI monitoring of brain damage in the neonatal ventral hippocampal lesion rat model of schizophrenia. Hippocampus. Feb;20(2):264-78.

VOHS J.L., Chambers R.A., Krishnan G.P., O’Donnell B.F., Berg S., Morzorati S.L. GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophrenia. Int J Neuropsychopharmacol. May;13(4):487-97.

LABRIE V., Lipina T., Roder J.C. Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia. Psychopharmacology (Berl). 2008 Oct;200(2):217-30.

LACHAPELLE F. [Replacing EC directive 86/609]. Bull Acad Natl Med. 2009 Nov;193(8):1793-802.

lINDSTROM L.H. Schizophrenia, the dopamine hypothesis and alpha2- adrenoceptor antagonists. Trends Pharmacol Sci. 2000 Jun;21(6):198-9.

GOTO Y., Grace A.A. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective. Int Rev Neurobiol. 2007;78:41- 68.

SEEMAN P., Ko F., Jack E., Greenstein R., Dean B. Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine- treated animal model of schizophrenia and in postmortem schizophrenia brain. Synapse. 2007 May;61(5):303-9.

INADA T., Nakamura A., Iijima Y. Relationship between catechol-O- methyltransferase polymorphism and treatment-resistant schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2003 Jul 1;120B(1):35-9.

TSENG K.Y., Lewis B.L., Lipska B.K., O’Donnell P. Post-pubertal disruption of medial prefrontal cortical dopamine-glutamate interactions in a developmental animal model of schizophrenia. Biol Psychiatry. 2007 Oct 1;62(7):730-8.

DeAN B., Bradbury R., Copolov D.L. Cannabis-sensitive dopaminergic markers in postmortem central nervous system: changes in schizophrenia. Biol Psychiatry. 2003 Apr 1;53(7):585-92.

GOTO Y., O’Donnell P. Prefrontal lesion reverses abnormal mesoaccumbens response in an animal model of schizophrenia. Biol Psychiatry. 2004 Jan 15;55(2):172-6.

LIPSKA B.K. Using animal models to test a neurodevelopmental hypothesis of schizophrenia. J Psychiatry Neurosci. 2004 Jul;29(4):282-6.

LIPSKA B.K., Jaskiw G.E., Chrapusta S., Karoum F., Weinberger D.R. Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat. Brain Res. 1992 Jul 10;585(1-2):1-6.

LIPSKA B.K., Weinberger D.R. Prefrontal cortical and hippocampal modulation of dopamine-mediated effects. Adv Pharmacol. 1998;42:806-9.

LIPSKA B.K., Weinberger D.R. Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats. Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8906-10.

LIPSKA B.K., Lerman D.N., Khaing Z.Z., Weinberger D.R. The neonatal ventral hippocampal lesion model of schizophrenia: effects on dopamine and GABA mRNA markers in the rat midbrain. Eur J Neurosci. 2003 Dec;18(11):3097-104.

LIPSKA B.K., Weinberger D.R. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology. 2000 Sep;23(3):223-39.

LIPSKA B.K., Jaskiw G.E., Weinberger D.R. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology. 1993 Aug;9(1):67-75.

FLORES G., Barbeau D., Quirion R., Srivastava L.K. Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus. J Neurosci. 1996 Mar 15;16(6):2020-6.

le PEN G., Gaudet L., Mortas P., Mory R., Moreau J.L. Deficits in reward sensitivity in a neurodevelopmental rat model of schizophrenia.

Psychopharmacology (Berl). 2002 Jun;161(4):434-41.

SUMIYOSHI T., Tsunoda M., Uehara T., Tanaka K., Itoh H., Sumiyoshi C., et al. Enhanced locomotor activity in rats with excitotoxic lesions of the

entorhinal cortex, a neurodevelopmental animal model of schizophrenia: behavioral and in vivo microdialysis studies. Neurosci Lett. 2004 Jul 1;364(2):124-9.

WOOD G.K., Lipska B.K., Weinberger D.R. Behavioral changes in rats with early ventral hippocampal damage vary with age at damage. Brain Res Dev Brain Res. 1997 Jul 18;101(1-2):17-25.

LIPSKA B.K., al-Amin H.A., Weinberger D.R. Excitotoxic lesions of the rat medial prefrontal cortex. Effects on abnormal behaviors associated with neonatal hippocampal damage. Neuropsychopharmacology. 1998 Dec;19(6):451-64.

AL-AMIN H.A., Shannon Weickert C., Weinberger D.R., Lipska B.K. Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus. Biol Psychiatry. 2001 Mar 15;49(6):528-39.

LIPSKA B.K., Halim N.D., Segal P.N., Weinberger D.R. Effects of reversible inactivation of the neonatal ventral hippocampus on behavior in the adult rat. J Neurosci. 2002 Apr 1;22(7):2835-42.

WOOD G.K., Quirion R., Srivastava L.K. Early environment contributes to developmental disruption of MPFC after neonatal ventral hippocampal lesions in rats. Synapse. 2003 Dec 1;50(3):223-32.

SAMS-DODD F., Lipska B.K., Weinberger D.R. Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology (Berl). 1997 Aug;132(3):303-10.

BECKER A., Grecksch G., Bernstein H.G., Hollt V., Bogerts B. Social behaviour in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis. Psychopharmacology (Berl). 1999 Jun;144(4):333-8.

AlQUICER G., Silva-Gomez A.B., Peralta F., Flores G. Neonatal ventral hippocampus lesion alters the dopamine content in the limbic regions in postpubertal rats. Int J Dev Neurosci. 2004 Apr;22(2):103-11.

LE PEN G., Moreau J.L. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology. 2002 Jul;27(1):1-11.

WOLF R., Matzke K., Paelchen K., Dobrowolny H., Bogerts B., Schwegler H. Reduction of Prepulse Inhibition (PPI) after neonatal excitotoxic lesion of the ventral thalamus in pubertal and adult rats. Pharmacopsychiatry. May;43(3):99-109.

WEINER I. The “two-headed” latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.Psychopharmacology (Berl). 2003 Sep;169(3-4):257-97.49.

VOHS J.L., Chambers R.A., Krishnan G.P., O’Donnell B.F., Hetrick W.P., KAISeR S.T., et al. Auditory sensory gating in the neonatal ventral hippocampal lesion model of schizophrenia. Neuropsychobiology. 2009;60(1):12-22.

XU R., Hranilovic D., Fetsko L.A., Bucan M., Wang Y. Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice. Mol Psychiatry. 2002;7(10):1075-82.


May 30, 2019


Detalles sobre esta monografía

ISBN-13 (15)


ISBN-13 de la coeditorial (24)